Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 4Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myeloid, Acute 3Pancreatic Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Colonic Neoplasms 1

Interventions

fludarabine phosphate 10Cyclophosphamide 10Peripheral Blood Stem Cell Transplantation 9Cyclosporine 7Mycophenolic Acid 6Filgrastim 6Antilymphocyte Serum 6Whole-Body Irradiation 5Busulfan 5Radiotherapy 4Psychiatric Rehabilitation 4Cytarabine 4Methylprednisolone 3Methotrexate 3Melphalan 3Cord Blood Stem Cell Transplantation 3Aprepitant 3thymoglobulin 2Therapeutics 2Tacrolimus 2Polymerase Chain Reaction 2Ondansetron 2Mesna 2Flow Cytometry 2Dexamethasone 2Calcium Dobesilate 2Analgesia 2sargramostim 1plerixafor 1fludarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Myeloproliferative Disorders × Decitabine × Clear all
NCT02121418 2018-04-13

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

University of Washington

Phase NA Completed
12 enrolled 10 charts
Myeloid

Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡